Aethlon Medical holders report 2.3% warrant stake
Aethlon Medical Inc. has three reporting persons – Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC – who report beneficial ownership of its common stock through a warrant position.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aethlon Medical Inc. has three reporting persons – Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC – who report beneficial ownership of its common stock through a warrant position. As of the close of business on June 30, 2026, they may be deemed to beneficially own 55,556 shares of common stock issuable upon exercise of a warrant held by Intracoastal (the “Intracoastal Warrant”). This stake represents approximately 2.3% of Aethlon Medical’s common stock.
The percentage is based on 2,370,560 shares of common stock outstanding as of June 8, 2026, plus the 55,556 warrant shares. All 55,556 shares are reported with shared voting and dispositive power, and no shares are held with sole voting or dispositive power. The reporting group indicates ownership of 5 percent or less of the class.
Key Figures
Key Terms
beneficial ownership financial
warrant financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Aethlon Medical (AEMD) does Intracoastal Capital and its affiliates report owning?
Who are the reporting persons in this Aethlon Medical (AEMD) Schedule 13G/A?
How was the 2.3% ownership in Aethlon Medical (AEMD) calculated?
AI-generated analysis. How Rhea-AI works. Not financial advice.